Evidence map›Paper›PMID 37824510›Full record

ArticleACS nano2023

Amphiphilic Particle-Stabilized Nanoliter Droplet Reactors with a Multimodal Portable Reader for Distributive Biomarker Quantification.

Vishwesh Shah, Xilin Yang, Alyssa Arnheim, Shreya Udani, Derek Tseng, Yi Luo, Mengxing Ouyang, Ghulam Destgeer, Omai B Garner, Hatice C Koydemir and 2 more

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lab on a Particle Technologies.Analytical chemistry · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Vishwesh ShahDepartment of Bioengineering, University of California - Los Angeles, Los Angeles, California 90095, United States.ORCID 0009-0006-8026-1260
Xilin YangDepartment of Electrical and Computer Engineering, University of California - Los Angeles, Los Angeles, California 90095, United States.
Alyssa ArnheimDepartment of Bioengineering, University of California - Los Angeles, Los Angeles, California 90095, United States.
Shreya UdaniDepartment of Bioengineering, University of California - Los Angeles, Los Angeles, California 90095, United States.
Derek TsengDepartment of Electrical and Computer Engineering, University of California - Los Angeles, Los Angeles, California 90095, United States.
Yi LuoDepartment of Electrical and Computer Engineering, University of California - Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0001-9442-547X
Mengxing OuyangDepartment of Bioengineering, University of California - Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0002-7824-617X
Ghulam DestgeerDepartment of Electrical Engineering, Technical University of Munich, Munich 80333, Germany.
Omai B GarnerDepartment of Pathology and Laboratory Medicine, University of California - Los Angeles, Los Angeles, California 90095, United States.
Hatice C KoydemirCenter for Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States.
Aydogan OzcanDepartment of Electrical and Computer Engineering, University of California - Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0002-0717-683X
Dino Di CarloDepartment of Bioengineering, University of California - Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0003-3942-4284
University of California, Los Angeles · USCalifornia NanoSystems Institute · USTechnical University of Munich · DETexas A&M Engineering Experiment Station

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compartmentalization, leveraging microfluidics, enables highly sensitive assays, but the requirement for significant infrastructure for their design, build, and operation limits access. Multimaterial particle-based technologies thermodynamically stabilize monodisperse droplets as individual reaction compartments with simple liquid handling steps, precluding the need for expensive microfluidic equipment. Here, we further improve the accessibility of this lab on a particle technology to resource-limited settings by combining this assay system with a portable multimodal reader, thus enabling nanoliter droplet assays in an accessible platform. We show the utility of this platform in measuring N-terminal propeptide B-type natriuretic peptide (NT-proBNP), a heart failure biomarker, in complex medium and patient samples. We report a limit of detection of ∼0.05 ng/mL and a linear response between 0.2 and 2 ng/mL in spiked plasma samples. We also show that, owing to the plurality of measurements per sample, "swarm" sensing acquires better statistical quantitation with a portable reader. Monte Carlo simulations show the increasing capability of this platform to differentiate between negative and positive samples, i.e., below or above the clinical cutoff for acute heart failure (∼0.1 ng/mL), as a function of the number of particles measured. Our platform measurements correlate with gold standard ELISA measurement in cardiac patient samples, and achieve lower variation in measurement across samples compared to the standard well plate-based ELISA. Thus, we show the capabilities of a cost-effective droplet-reader system in accurately measuring biomarkers in nanoliter droplets for diseases that disproportionately affect underserved communities in resource-limited settings.

Indexed as

Heart FailureMicrofluidicsBiomarkersEnzyme-Linked Immunosorbent AssayHumansVasodilator AgentsBiomarkersVasodilator Agentsbiomarker detectiondropletELISAlow-cost sensorsportable readerstatistical quantitation

Identifiers

PMID37824510
PMCPMC10604076
OpenAlexW4387568499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.